Ketamine Therapy in Massachusetts

How Mindbloom Works in Massachusetts

1. Complete an Online Assessment

Your journey begins with a comprehensive medical intake that gathers your health history, current medications, and treatment goals. A Massachusetts-licensed psychiatric clinician reviews your information to determine whether ketamine therapy is appropriate for your situation. This step is designed to screen for contraindications and ensure that treatment is both safe and clinically indicated.

2. Meet with a Massachusetts-Licensed Clinician

You'll have a video consultation with a psychiatric clinician licensed to practice in Massachusetts. During this appointment, your clinician screens for contraindications, discusses your mental health history, answers your questions, and, if appropriate, develops a personalized treatment plan. This includes establishing your dosing protocol.

3. Prepare for Your At-Home Sessions

Once your treatment plan is set, Mindbloom ships your Bloombox, an experience toolkit that includes everything you need for your sessions at home. You'll also arrange for a peer treatment monitor to be present during each session. This is a trusted adult who stays with you throughout the experience for safety and support. You'll receive access to the Mindbloom app, which contains session preparation materials and guided content.

4. Conduct Sessions at Home

Right before your first session, you'll meet virtually with a Mindbloom guide, a trained facilitator who helps you set intentions and prepare for the experience. During each session, you'll use the Mindbloom app to access one of over 150 curated soundscapes designed to support the therapeutic experience. Sessions typically last 60-90 minutes. Your peer treatment monitor remains present throughout.

5. Integrate and Build on Your Progress

Between sessions, your Mindbloom guide provides 1:1 coaching and is available via unlimited messaging to help you process your experiences and translate insights into lasting change. You'll also have access to daily Integration Circles, live group sessions facilitated by trained practitioners, along with journaling prompts, breathing exercises, and other app-based tools designed to deepen the therapeutic benefit of each session.

Mental Health in Massachusetts

Massachusetts ranked 6th overall in Mental Health America's 2025 report⁵, and the state has 813.9 mental health providers per 100,000 residents, ranking 2nd nationally.⁶ The state's suicide rate of 9.4 per 100,000 is among the lowest in the country.⁷ However, those top-line numbers mask persistent geographic access challenges. Provider availability remains concentrated in the Boston metro area, and the state still has more than 50 federally designated mental health professional shortage areas⁸, leaving communities throughout Western Massachusetts, Cape Cod, the Berkshires, the South Shore, and the North Shore underserved. For Massachusetts residents living with depression, anxiety, PTSD, or related conditions like OCD, burnout, grief, and chronic pain, telehealth-based treatment offers a way to access specialized care without long wait times or hours of travel.

Mindbloom's Published Outcomes for Depression, Anxiety, and PTSD

Mindbloom's clinical outcomes for depression and anxiety are drawn from two peer-reviewed studies published in the Journal of Affective Disorders ^1,2, representing one of the largest real-world datasets on at-home ketamine therapy. All data reflects outcomes from Mindbloom clients treated under Mindbloom's clinical protocol.

Depression

89% of clients reported meaningful improvement in depression symptoms. Among those assessed using validated clinical measures, 56.4% met criteria for clinically significant depression response. ^1,2

Anxiety

89% of clients reported improvement in anxiety symptoms. 62.2% achieved clinically significant change in anxiety symptoms, with 56.1% meeting criteria for anxiety response on validated scales. ^1,2

PTSD

In a separate real-world analysis of 374 Mindbloom PTSD program completers, 92% reported symptom improvement. 79.7% met criteria for treatment response, and 60.7% achieved remission. ³

Sleep

In another retrospective real-world analysis evaluating 13,963 program completers, 77% reported clinically meaningful improvements in sleep, with a 49% average improvement in sleep disturbances, and only 2.5% reporting worsened sleep. ⁴

Safety

Across more than 700,000 completed sessions, Mindbloom has observed a 4-5% side effect rate. ^1,2 The most commonly reported effects, including nausea, dizziness, and transient dissociation, are typically mild and resolve within the post-session window.

Safety Protocols

Mindbloom's clinical program is built around multiple layers of medical oversight:

• Medical screening: Before treatment begins, your clinician conducts a thorough evaluation for contraindications, including cardiovascular screening with blood pressure and heart rate assessment.
• Session monitoring: A peer treatment monitor is required to be physically present during every session, providing real-time support and an additional layer of safety.
• Follow-up care: Your clinician monitors your response to treatment and adjusts dosing or protocol as needed. Tolerability is assessed on an ongoing basis throughout your program.

Where Mindbloom Serves in Massachusetts

Mindbloom serves Massachusetts residents statewide through its telehealth platform, making evidence-based ketamine therapy available to communities that have historically had limited access to specialized mental health treatment. In-clinic ketamine therapy options in Massachusetts are concentrated in the Boston area, leaving many communities throughout Western Massachusetts, Cape Cod, the Berkshires, the South Shore, and the North Shore underserved. Mindbloom's program is accessible from anywhere in Massachusetts with an internet connection.

Mindbloom serves residents in and around: Boston, Worcester, Springfield, Cambridge, Lowell, Brockton, New Bedford, Fall River, Quincy, Newton, Framingham, Somerville, Lynn, Lawrence, Haverhill, Plymouth, and throughout the state, including Cape Cod, the Berkshires, Western Massachusetts, the South Shore, and the North Shore.

Mindbloom is not limited to these areas. Any Massachusetts resident with a valid Massachusetts address can access the program.

How Ketamine Therapy Options Compare in Massachusetts

Several forms of ketamine therapy are available in Massachusetts, each with different settings, costs, and accessibility:

• IV ketamine infusion: Administered intravenously at an in-clinic facility with on-site medical staff. Typically costs $400 to $800+ per infusion and is limited to major metro areas.
• IM ketamine injection: Administered intramuscularly at an in-clinic facility with on-site medical staff. Typically costs $300-$600 per injection and is limited to major metro areas.
• Spravato (esketamine): An FDA-approved nasal spray administered in a certified healthcare setting with a required 2-hour post-dose observation period. Covered by some insurance plans; copays vary.
• Mindbloom: Sublingual tablet administered at home with a peer treatment monitor present. Costs $165-$215 per session and is available to residents statewide via telehealth.

Ketamine is a Schedule III controlled substance that has been FDA-approved as an anesthetic since 1970. Its use for depression, anxiety, and PTSD is considered off-label, meaning the medication is being prescribed for a condition outside its original FDA indication. Off-label prescribing is a well-established, routine practice in medicine. Ketamine's use for mental health conditions is supported by a robust body of clinical research on how ketamine works at the neurological level.

How Much Ketamine Therapy Costs in Massachusetts

In-clinic IV ketamine infusions in Massachusetts typically cost $400 to $800+ per session, while IM injections range from $300 to $600. Spravato (esketamine) may be covered by some insurance plans, with copays varying. Mindbloom sessions cost $165-$215 depending on the program selected, representing savings of approximately 60-70% compared to in-clinic IV infusion options. Mindbloom sessions are HSA and FSA eligible, and Mindbloom provides superbills that you can submit to your insurance provider for potential out-of-network reimbursement. Learn more about insurance and payment options.

Why Massachusetts Residents Choose Mindbloom

• Peer-reviewed research: Mindbloom's outcomes are published in peer-reviewed journals, meaning the data comes from the actual program you'd enroll in, not a separate clinical trial. Research was conducted in collaboration with academic and clinical institutions.
• Scale and experience: With more than 700,000 completed sessions, Mindbloom is one of the largest at-home ketamine therapy providers in the country.
• Comprehensive care model: Treatment extends well beyond the medication itself. Your program includes 1:1 guide coaching, unlimited messaging, daily Integration Circles, over 150 curated soundscapes, and app-based integration tools.
• Statewide access: No in-person clinic visits required. Mindbloom's telehealth model reaches every corner of Massachusetts, from Boston to Western Massachusetts to Cape Cod and the Berkshires.
• Affordability: At $165-$215 per session with HSA/FSA eligibility and superbill support, Mindbloom makes ketamine therapy financially accessible.

How to Choose a Ketamine Therapy Provider in Massachusetts

When evaluating ketamine therapy providers, whether in-clinic or telehealth, consider the following:

• Clinical oversight: Is treatment prescribed and monitored by a licensed psychiatric clinician? Is there a structured intake process with contraindication screening?
• Published outcomes: Does the provider publish clinical outcomes from their own patient population? Is the data peer-reviewed?
• Safety protocols: What monitoring is required during sessions? What happens if you experience a side effect or adverse reaction?
• Integration support: Does the program offer support between sessions, such as coaching, integration tools, and group sessions, or is it medication-only?
• Transparency: Is pricing clear? Are the clinician's credentials and the program's clinical protocol publicly available?